5
Participants
Start Date
April 19, 2022
Primary Completion Date
June 3, 2022
Study Completion Date
June 3, 2022
GLPG3667 capsule
On Day 1, participants will receive a single oral dose of GLPG3667
[14C]-GLPG3667 solution for infusion
On Day 1, participants will receive a single microtracer microdose of \[14C\]-GLPG3667 as an intravenous infusion
[14C]-GLPG3667 capsule
On Day 1, participants will receive a single oral dose of \[14C\]-GLPG3667
Quotient Sciences Limited, Nottingham
Lead Sponsor
Galapagos NV
INDUSTRY